Literature DB >> 3678131

Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor.

S B Rodan1, G Wesolowski, K Thomas, G A Rodan.   

Abstract

Purified acidic fibroblast growth factor (aFGF) from bovine brain stimulates the proliferation of calvaria-derived osteoblastic cells. Maximum stimulation, relative to corresponding controls, was seen at 0.2% serum (2- to 3-fold), and no stimulation was seen in the absence of serum or under serum replete conditions. The effect was dose-dependent with an ED50 of around 750 pg/ml (47 pM). aFGF (5 ng/ml) sustained the growth of calvaria cells in culture during multiple passages (72 days) at 0.2% serum. In DNA synthesis assays aFGF produced 2- to 4-fold stimulation; insulin-like growth factor I had a slight effect on DNA synthesis on its own, but enhanced the effect of aFGF 2-fold. In cells fully stimulated by epidermal growth factor (5-fold), aFGF had no further effect. Stimulation of DNA synthesis peaked at 5 ng/ml, while higher concentrations were inhibitory. Recombinant aFGF (bovine sequence) also stimulated cell proliferation (1.5-fold), and its potency was augmented by heparin (50 micrograms/ml), about 2-fold. Using simultaneous histochemical staining for alkaline phosphatase activity and [3H]thymidine nuclear uptake we found that aFGF stimulates DNA synthesis to the same extent in alkaline phosphatase-rich (osteoblastic) and alkaline phosphatase-poor (nonosteoblastic) cells. However, after cell division there is a significant decrease in PTH-responsive adenylate cyclase (2- to 3-fold) and in alkaline phosphatase levels (4- to 8-fold). These findings indicate that aFGF is mitogenic to rat calvaria osteoblastic cells, its action requires additional factors, and its growth stimulation is associated with a reduction in phenotypic expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678131     DOI: 10.1210/endo-121-6-1917

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Growth regulatory factors and bone.

Authors:  G R Mundy; D Chen; M Zhao; S Dallas; C Xu; S Harris
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Heterotopic ossification: clinical and cellular aspects.

Authors:  J R Sawyer; M A Myers; R N Rosier; J E Puzas
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

3.  Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin.

Authors:  S Vukicevic; F P Luyten; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 4.  Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors.

Authors:  Katarina T Borer
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 5.  Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation.

Authors:  J B Lian; G S Stein
Journal:  Iowa Orthop J       Date:  1995

6.  1α,25-Dihydroxyvitamin D(3) down-regulates pleiotrophin messenger RNA expression in osteoblast-like cells.

Authors:  M Tamura; F Ichikawa; R P Guillerman; T F Deuel; M Nodal
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

7.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.

Authors:  Xinping Zhang; Edward M Schwarz; Donald A Young; J Edward Puzas; Randy N Rosier; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

8.  Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation.

Authors:  Hongbin Liu; Rongrong Zhang; Di Chen; Babatunde O Oyajobi; Ming Zhao
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

9.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Authors:  S Harada; J A Nagy; K A Sullivan; K A Thomas; N Endo; G A Rodan; S B Rodan
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

10.  Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells.

Authors:  T Ogata; J M Wozney; R Benezra; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.